Navigation Links
Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
Date:9/13/2009

ile in both formulations and demonstrating the bioequivalence of the oral tablet formulation to solution. In vitro studies demonstrated the high metabolic stability of NKTR-118 compared to naloxone. Results of in vitro testing indicate that NKTR-118 has a low potential for clinically important drug-drug interactions, thereby facilitating the combination of NKTR-118 with a wide range of drugs in clinical development.

NKTR-118 Phase 2 Clinical Trial Data to be presented in Oral Plenary Session at ACG 2009

Nektar also announced today that results from a separate Phase 2 clinical trial of NKTR-118 have been accepted for presentation at an oral plenary session of the American College of Gastroenterology (ACG) 2009 Annual Scientific Meeting to be held in San Diego on October 27, 2009. The data will be presented by Dr. Lynn Webster, medical director of Lifetree Clinical Research and lead clinical investigator of the Phase 2 trial.

Topline data from this Phase 2 study showed that NKTR-118 met the primary endpoint of increase in spontaneous bowel movements over the baseline period in a double-blind, randomized, placebo-controlled study in 208 patients with opioid-induced constipation, while preserving the analgesic effect of opioid by reducing the blood-brain barrier penetration.

Download Today's Data Presentations for NKTR-118

The poster presentations presented today at the ACCP 38th Annual Meeting (Poster Session 1, 6:00 - 8:00 PM Central time) can be found on Nektar's website at http://www.nektar.com/product_pipeline/cns_pain_oral_nktr-118and119.html

ACCP Poster #140: "NKTR-118, an oral peripheral opioid antagonist, has low potential for drug-drug interactions"

ACCP P
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... COLUMBUS, Ohio, July 24, 2014  Mettler-Toledo International Inc. ... results for 2014.  Provided below are the highlights: ... in the quarter compared with the prior year. Reported ... currency. , Net earnings per diluted share as ... second quarter of 2013. Adjusted EPS was $2.57, an ...
(Date:7/24/2014)... BUENA, N.J. , July 24, 2014 ... New Jersey based specialty generic pharmaceutical company, ... resignation from its Board of Directors.  Mr. Finio has ... company, and under the terms of his acceptance of ... continue in his role as Director for IGI Laboratories, ...
(Date:7/24/2014)... Sciences, Inc. (NASDAQ: ALIM ) ("Alimera"), a ... commercialization of prescription ophthalmic pharmaceuticals, today announced that it ... financial results after the market close on Thursday, August ... the same day at 4:30 p.m. ET. ... Dan Myers , President and Chief Executive Officer, and ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2Alimera Sciences To Release Second Quarter 2014 Results 2
... NORTH WALES, Pa., Aug. 18 AirPal ®, ... and positioning technology, has announced the expansion of its ... positioning functionality. "This announcement marks the launch ... Positioning™ systems," said Jim Weedling, President AirPal, Inc.  "Among ...
... LAUDERDALE, Fla., Aug. 18 After a lengthy ... of power mobility products and services, has selected ... to help strengthen and broaden the company,s brand ... Advertising and Daggerwing, Omnicom,s team will include Javelin ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2Omnicom Adds National Healthcare Giant to Client Roster 2Omnicom Adds National Healthcare Giant to Client Roster 3
(Date:7/24/2014)... Researchers at Le Bonheur Children,s Hospital and the University ... clinical trial of a new drug shown to safely ... adult volunteers intranasally infected with respiratory syncytial virus (RSV). ... tract infections in young children in the United States ... labs of Infectious Disease Specialist John DeVincenzo, MD. DeVincenzo,s ...
(Date:7/24/2014)... As the age of marriage and ... as a way to ensure future family building options ... advancing reproductive age. Vitrification technology, a fast freeze method ... technology that allows a woman to have multiple eggs ... which are then stored for future use. When circumstances ...
(Date:7/24/2014)... In a recent report by CBS News, ... an end to criminal penalties associated with possession of small ... marijuana reform in Washington DC, giving it one of the ... criminal penalties for possession of one ounce of marijuana or ... of more than an ounce of marijuana remain criminal offenses ...
(Date:7/24/2014)... Taylor, M.D., director of The Miriam Hospital,s HIV/Viral ... Rhode Island Medical Journal special edition, ... virus infection (hep c or HCV) is feasible, ... other health challenges, and improve health care disparities. ... Taylor says, include lack of funding earmarked for ...
(Date:7/24/2014)... The U.S. Food & Drug ... Entertainment Industries Council (EIC) have teamed with entertainment ... Story on a first-of-its-kind Decorative Contact Lens ... illegal and unsafe lens use to the forefront. ... tens-of-thousands, is now releasing its second production which ...
Breaking Medicine News(10 mins):Health News:RSV research breakthrough to help infected children 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 2Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 3Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 4
... the University of Michigan Cardiovascular Center shows being a woman ... a severe heart attack. U-M researchers and colleagues in ... as an angioplasty had higher unadjusted in-hospital heart attack deaths. ... women,s ages and additional health problems not gender, says ...
... Mothers who are depressed respond differently to their crying ... according to brain scans at the University of Oregon, ... in non-depressed moms. An infant crying is normal, ... says Jennifer C. Ablow, professor of psychology. For years, ...
... -- People with inflammatory bowel disease have double the ... thromboembolism) in the legs or lungs as do people ... Inflammatory bowel disease includes Crohn,s disease and ulcerative colitis, ... weight loss and other problems. Venous thromboembolism (VTE) ...
... may give patients hope for a cure. Laboratory ... Huntington,s disease patients determined that an overactive protein triggers ... die. Toning down the activity of that protein, known ... cells alive, according to the research team led by ...
... medication tifacogin does not appear to improve outcomes of ... study conducted by researchers from North and South America, ... potential benefit in the sCAP subgroup of an earlier ... online ahead of the print edition of the American ...
... for families as they try to confront a family member ... that there,s a society on the Internet that is dedicated ... behavior. University of Cincinnati communication researchers are reporting ... networks grow on the Web. This emerging Online Negative Enabling ...
Cached Medicine News:Health News:Study suggests gender does not play a role in risk of death from heart attack 2Health News:Crying baby draws blunted response in depressed mom's brain 2Health News:Crying baby draws blunted response in depressed mom's brain 3Health News:People With Bowel Disease at Higher Risk of Blood Clot in Lungs, Legs 2Health News:Huntington's disease breakthrough equals hope for patients 2Health News:Anti-clotting agent does not improve outcomes of patients with severe pneumonia 2Health News:Anti-clotting agent does not improve outcomes of patients with severe pneumonia 3Health News:Research uncovers a secret society connecting through the Internet 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: